Engineered hla molecules useful for t cell and nk cell activation and expansion
AssigneeMemorial Sloan Kettering Cancer Center
InventorsKatharine C Hsu, Mohammed Kazim Panjwani
Life of this patent
Estimating the term…
Loading patent…
AssigneeMemorial Sloan Kettering Cancer Center
InventorsKatharine C Hsu, Mohammed Kazim Panjwani
Estimating the term…
In some aspects, the present invention involves chimeric recombinant HLA proteins that are derived from HLA-E proteins and comprise a leader peptide from an HLA-A, HLA-B, HLA-C or HLA-G protein. In some aspects, the present invention also involves nucleic acid molecules encoding such recombinant HLA proteins, vectors comprising such nucleic acid molecules, host cells comprising such recombinant HLA proteins, and various related compositions. In some aspects, the present invention also involves methods of use of such recombinant HLA proteins, nucleic acid molecules, vectors, host cells and compositions.
A recombinant HLA protein comprising, from N-terminal to C-terminal:
A nucleic acid molecule encoding a recombinant HLA protein according to any of the preceding claims.
Dependencies are inferred from the claim text.